Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Nov 1;88(9):3451-5.

A deletion mutation causes hemophilia B in Lhasa Apso dogs

Affiliations
  • PMID: 8896410
Free article

A deletion mutation causes hemophilia B in Lhasa Apso dogs

A E Mauser et al. Blood. .
Free article

Abstract

Hemophilia B is a bleeding disorder caused by a deficiency of clotting factor IX (FIX). A colony of FIX deficient Lhasa Apso dogs has been established and the molecular basis of hemophilia B has been determined. The plasma factor IX levels were < 1% of normal canine levels in affected dogs. A complex deletion mutation at nucleotides 772-777 was found when hepatocyte cDNA from a hemophilia B dog was sequenced. The sequence was identical to the normal canine sequence except for a deletion including nucleotides 772-776 and a C-->T transition at nucleotide 777. The mutation results in mRNA instability and a premature termination codon in the nucleotide sequence encoding the activation peptide. The mutation was verified by sequencing genomic DNA from an FIX-deficient dog. A genetic test for the detection of heterozygous animals was established using heteroduplex analysis. Although hemophilia B has been described in many dog breeds, this is only the second mutation to be sequenced. The Lhasa Apso dog model should be valuable for evaluating novel strategies for treating hemophilia B such as gene therapy.

PubMed Disclaimer

Similar articles

Cited by

  • Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs.
    Nichols TC, Whitford MH, Arruda VR, Stedman HH, Kay MA, High KA. Nichols TC, et al. Hum Gene Ther Clin Dev. 2015 Mar;26(1):5-14. doi: 10.1089/humc.2014.153. Epub 2015 Feb 12. Hum Gene Ther Clin Dev. 2015. PMID: 25675273 Free PMC article. Review.
  • Gene therapy for the hemophilias.
    Kay MA, High K. Kay MA, et al. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9973-5. doi: 10.1073/pnas.96.18.9973. Proc Natl Acad Sci U S A. 1999. PMID: 10468539 Free PMC article. Review. No abstract available.
  • Current animal models of hemophilia: the state of the art.
    Yen CT, Fan MN, Yang YL, Chou SC, Yu IS, Lin SW. Yen CT, et al. Thromb J. 2016 Oct 4;14(Suppl 1):22. doi: 10.1186/s12959-016-0106-0. eCollection 2016. Thromb J. 2016. PMID: 27766048 Free PMC article. Review.
  • Animal models of hemophilia.
    Sabatino DE, Nichols TC, Merricks E, Bellinger DA, Herzog RW, Monahan PE. Sabatino DE, et al. Prog Mol Biol Transl Sci. 2012;105:151-209. doi: 10.1016/B978-0-12-394596-9.00006-8. Prog Mol Biol Transl Sci. 2012. PMID: 22137432 Free PMC article. Review.
  • Genetics of equine bleeding disorders.
    Dahlgren AR, Tablin F, Finno CJ. Dahlgren AR, et al. Equine Vet J. 2021 Jan;53(1):30-37. doi: 10.1111/evj.13290. Epub 2020 Jun 23. Equine Vet J. 2021. PMID: 32463964 Free PMC article. Review.

Publication types

LinkOut - more resources